May 15, 2018 — Medic Vision Imaging Solutions Ltd. announced that the U.S. Food and Drug Administration (FDA) has cleared its latest product, iQMR (intelligent Quick MR).
Medic Vision's new iterative image reconstruction technology enhances noisy magnetic resonance imaging (MRI) images and significantly increases signal-to-noise ratio (SNR). The new technology's capabilities enable the use of short MRI protocols and allow increased productivity, fewer repeating scans and a better patient experience. iQMR supports MRI scanners of all vendors and models.
Medic Vision is also a provider of third-party computed tomography (CT) dose management and reduction solutions, including its flagship products SafeCT and SafeCT-29.
Medic Vision will showcase iQMR at the upcoming American Society of Neuroradiology (ASNR) 56th Annual Meeting, June 2-7 in Vancouver, B.C., Canada. At the meeting, Prof. Lawrence N. Tanenbaum, M.D., FACR, VP and director of CT, MR and advanced imaging at RadNet, will present the results of a clinical study demonstrating the ability to reduce routine brain exam scan time by 30 percent without adversely affecting image quality using iQMR.
Image courtesy of Medic Vision Imaging Solutions